Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritis.

Published in: Rheumatology (Oxford, England) (2021)

Keyphrases